Key result
Mitral valve repair offers improved survival and ventricular function over replacement, with 90% repair feasibility in degenerative and ischemic disease compared to limited durability in rheumatic valves.
Why the study?
Does mitral valve repair improve outcomes compared to mitral valve replacement in patients with mitral valve dysfunction?
Does mitral valve repair improve outcomes compared to mitral valve replacement in patients with mitral valve dysfunction?
Mitral valve repair is the preferred treatment for mitral valve dysfunction, offering better survival and fewer complications than replacement, particularly for degenerative and ischemic etiologies.
Answers are grounded in this paper and cite their sources.
May support repair preference in degenerative disease; leaves open need for RCTs across etiologies.
Mitral valve repair is the procedure of choice to treat mitral valve dysfunction. Advantages of mitral valve repair over mitral valve replacement include improved long-term survival, better preservation of left ventricular function, and greater freedom from endocarditis, thromboembolism, and anticoagulant-related hemorrhage. The feasibility and durability of mitral valve repair depend upon the etiology of mitral valve dysfunction. In degenerative and ischemic mitral valve diseases, valve repair is possible in 90% of cases and freedom from reoperation is high. In contrast, rheumatic valves are less amenable to repair and durability is limited. Most isolated valve operations can be performed in a minimally invasive fashion using a partial upper sternotomy. In patients with atrial fibrillation and mitral valve disease, the Maze procedure or pulmonary vein isolation is performed, eliminating atrial fibrillation and the need for long-term anticoagulation.
No takes yet. Share an insight, caveat, or question.
Gillinov et al. (2003) conducted a review in Mitral valve dysfunction. Mitral valve repair vs. Mitral valve replacement was evaluated. Mitral valve repair offers improved survival and ventricular function over replacement, with 90% repair feasibility in degenerative and ischemic disease compared to limited durability in rheumatic valves.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: